Yoon Ji Won, Jung Chan-Hyeon, Kim Min-Kyung, Park Hyo Eun, Park Kyong Soo, Jang Hak Chul, Moon Min Kyong, Choi Su-Yeon, Koo Bo Kyung
Department of Internal Medicine, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Republic of Korea.
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
PLoS One. 2017 Jun 2;12(6):e0178741. doi: 10.1371/journal.pone.0178741. eCollection 2017.
Debates whether metabolically healthy obesity (MHO) increases the cardiovascular risk might be due to the metabolic instability of MHO or the absence of a perfect definition of MHO. Therefore, we aimed to investigate the influence of the MHO phenotype on the coronary artery calcium score (CACS) progression according to definition of MHO.
We analyzed a retrospective cohort with a CACS of 0 at baseline and available serial CACS measurements taken ≥ 12 months apart (n = 1,218). Obesity was defined as BMI ≥ 25 kg/m2, and MHO was defined as obesity accompanied by ≤ 1 (MHO class I) or 0 (MHO class II) components of metabolic syndrome (MetS).
During a median follow-up of 45 months, 32.2% of MHO class I and 10.2% of MHO class II subjects developed MetS. Compared to non-obese/metabolically healthy subjects (reference group), hazard ratios (HR) for development of MetS were 2.174 (95% confidence interval [CI]: 1.513-3.124) and 1.166 (95% CI: 0.434-3.129) for MHO class I and II subjects, respectively. The MHO class I subjects showed a significantly increased risk of CACS progression as compared to the reference group (HR: 1.653; 95% CI: 1.144-2.390), whereas MHO class II subjects did not (HR: 1.195; 95% CI: 0.514-2.778). Among subjects with MHO class I, no significant CACS progression was observed in the subjects who maintained metabolic health during follow-up (HR: 1.448; 95% CI: 0.921-2.278).
The risks of metabolic deterioration and CACS progression were significant in subjects with MHO class I, but not in those with MHO class II.
关于代谢健康型肥胖(MHO)是否会增加心血管疾病风险的争论,可能源于MHO的代谢不稳定性或缺乏对MHO的完美定义。因此,我们旨在根据MHO的定义,研究MHO表型对冠状动脉钙化评分(CACS)进展的影响。
我们分析了一个回顾性队列,这些患者基线时CACS为0,且有间隔≥12个月的系列CACS测量值(n = 1218)。肥胖定义为体重指数(BMI)≥25 kg/m²,MHO定义为伴有≤1项(MHO I类)或0项(MHO II类)代谢综合征(MetS)成分的肥胖。
在中位随访45个月期间,MHO I类患者中有32.2%、MHO II类患者中有10.2%发生了MetS。与非肥胖/代谢健康的受试者(参照组)相比,MHO I类和II类患者发生MetS的风险比(HR)分别为2.174(95%置信区间[CI]:1.513 - 3.124)和1.166(95%CI:0.434 - 3.129)。与参照组相比,MHO I类患者的CACS进展风险显著增加(HR:1.653;95%CI:1.144 - 2.390),而MHO II类患者则没有(HR:1.195;95%CI:0.514 - 2.778)。在MHO I类患者中,随访期间维持代谢健康的患者未观察到显著的CACS进展(HR:1.448;95%CI:0.921 - 2.278)。
MHO I类患者存在代谢恶化和CACS进展的风险,而MHO II类患者则不存在。